PHIO CIK: 1533040

Phio Pharmaceuticals Corp.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−11.9
FY22:
−12.1
FY23:
−10.7
FY24:
−7.11
FY25:
−7.98
Change from FY21 to FY25
millions USD
FY21:
−0.05
FY22:
−0.12
FY23:
−0.01
FY24:
0.01
FY25:
−0.01
Change from FY21 to FY25
millions USD
FY21:
21.7
FY22:
−0.03
FY23:
7.41
FY24:
4.00
FY25:
23.6
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
−3.11
FY25:
15.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−11.9
FY22:
−12.3
FY23:
−10.8
FY24:
−7.11
FY25:
−7.99

All amounts in millions USD Data source:SEC EDGAR